Literature DB >> 15935550

Hypericin-mediated photodynamic therapy elicits differential interleukin-6 response in nasopharyngeal cancer.

Hongyan Du1, Boon-Huat Bay, Ratha Mahendran, Malini Olivo.   

Abstract

Cytokines induce inflammatory and immune responses in tumors after photodynamic therapy (PDT). Since there are no reports of IL-6 in nasopharyngeal cancer (NPC) cells following PDT, we evaluated IL-6 expression in two different NPC tumors after hypericin mediated PDT. Interleukin-6 transcription was significantly upregulated in PDT-treated CNE-2 poorly differentiated cells but not in HK1 well differentiated cells. In vivo, IL-6 mRNA expression was elevated in PDT-treated CNE-2 tumors but not in HK1 tumors. In conclusion, the study elucidated that the cell type, degree of histological differentiation and the basal expression of the cytokine influence the cytokine response following PDT.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15935550     DOI: 10.1016/j.canlet.2005.04.013

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  11 in total

Review 1.  Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies.

Authors:  Mans Broekgaarden; Ruud Weijer; Thomas M van Gulik; Michael R Hamblin; Michal Heger
Journal:  Cancer Metastasis Rev       Date:  2015-12       Impact factor: 9.264

2.  IL-6 potentiates tumor resistance to photodynamic therapy (PDT).

Authors:  Craig M Brackett; Barbara Owczarczak; Kimberley Ramsey; Patricia G Maier; Sandra O Gollnick
Journal:  Lasers Surg Med       Date:  2011-09       Impact factor: 4.025

3.  Photodynamic therapy-mediated modulation of inflammatory cytokine production by Epstein-Barr virus-infected nasopharyngeal carcinoma cells.

Authors:  Ho-Kee Koon; Kwok-Wai Lo; Kwok-Nam Leung; Maria Li Lung; Chris Chi-Kwong Chang; Ricky Ngok-Shun Wong; Wing-Nang Leung; Nai-Ki Mak
Journal:  Cell Mol Immunol       Date:  2010-03-15       Impact factor: 11.530

Review 4.  The effect of photodynamic therapy on tumor angiogenesis.

Authors:  Ramaswamy Bhuvaneswari; Yik Yuen Gan; Khee Chee Soo; Malini Olivo
Journal:  Cell Mol Life Sci       Date:  2009-03-31       Impact factor: 9.261

5.  Hypericin-photodynamic therapy leads to interleukin-6 secretion by HepG2 cells and their apoptosis via recruitment of BH3 interacting-domain death agonist and caspases.

Authors:  M Barathan; V Mariappan; E M Shankar; B J J Abdullah; K L Goh; J Vadivelu
Journal:  Cell Death Dis       Date:  2013-06-27       Impact factor: 8.469

Review 6.  Boosting Tumor-Specific Immunity Using PDT.

Authors:  Nicole Maeding; Thomas Verwanger; Barbara Krammer
Journal:  Cancers (Basel)       Date:  2016-10-06       Impact factor: 6.639

7.  Tropomyosin Receptor Kinase C Targeted Delivery of a Peptidomimetic Ligand-Photosensitizer Conjugate Induces Antitumor Immune Responses Following Photodynamic Therapy.

Authors:  Chin Siang Kue; Anyanee Kamkaew; Siew Hui Voon; Lik Voon Kiew; Lip Yong Chung; Kevin Burgess; Hong Boon Lee
Journal:  Sci Rep       Date:  2016-11-17       Impact factor: 4.379

8.  Hypericin-photodynamic therapy inhibits the growth of adult T-cell leukemia cells through induction of apoptosis and suppression of viral transcription.

Authors:  Lingling Xu; Xueqing Zhang; Wenzhao Cheng; Yong Wang; Kaining Yi; Zhilong Wang; Yiling Zhang; Linxiang Shao; Tiejun Zhao
Journal:  Retrovirology       Date:  2019-02-19       Impact factor: 4.602

9.  Population Variability of Main Secondary Metabolites in Hypericum lydium Boiss. (Hypericaceae).

Authors:  Cüneyt Çirak; Jolita Radusiene; Liudas Ivanauskas; Valdas Jakstas; Necdet Çamaş
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

10.  Inhibition of NF-κB in Tumor Cells Exacerbates Immune Cell Activation Following Photodynamic Therapy.

Authors:  Mans Broekgaarden; Milan Kos; Freek A Jurg; Adriaan A van Beek; Thomas M van Gulik; Michal Heger
Journal:  Int J Mol Sci       Date:  2015-08-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.